BMW Follows Tesla in China Price Rise as U.S. Auto Exports Head Into Reverse — Panjiva


BMW Follows Tesla in China Price Rise as U.S. Auto Exports Head Into Reverse

China 1758 Cons. Discr. - Autos 661 Tariffs 1169 U.S. 3297

Automaker BMW has increased the sales price of its X-series of SUVs in China by 5% to 7%, the Financial Times reports, in response to duties applied by the Chinese government in retaliation for America’s section 301 duties. As outlined in Panjiva research of July 9 BMW’s move follows an 18% rise implemented by Tesla for its S-series immediately after the duties’ implementation while Daimler has indicated there will be a reduction in vehicle sales as a consequence of the duties.

Panjiva data shows U.S. exports to China of large-capacity cars (gasoline and diesel) such as BMW’s X-series reached 221,000 units in the 12 months to May 31, or 11.7% of the total. That followed a decline in shipments of 29.2% in the three months to May 31 on a year earlier vs. a 7.2% increase in total shipments. The average value per vehicle of the exports reached $34.7k over the 12 month period, or just 1.7% higher than a year earlier.


Chart segments U.S. exports of large-engined vehicles by destination on a monthly (dotted) and quarterly average (solid) basis.   Source: Panjiva

Exports from the U.S. accounted for 27.6% of BMW’s total Chinese imports in the 12 months to February 28, with completed vehicles accounting for 95.8% of U.S.-outbound shipments. One alternative may be for the company to shift assembly of the vehicles from the U.S. to another factory including its China joint venture or factories in Brazil or Egypt where “knockdown” component strategies are used.


Chart segments Chinese imports associated with BMW by country of origin and product (HS-6) in the 12 months to February 28, denominated in dollars.   Source: Panjiva

PANJIVA RESEARCH is a service provided by Panjiva, Inc. ("Panjiva") to relevant global subscribers, and are deemed to be Panjiva "Services" subject to the Panjiva Terms & Conditions of Use. Information contained within or made available via the Services is for informational purposes only and nothing in the Services shall constitute or be construed as an offering of financial instruments, or as investment advice or recommendations by Panjiva, Inc. or its affiliates of an investment strategy or whether to "buy", "sell" or "hold" an investment. The Services may include views and commentary about customers of Panjiva. No aspect of the Services is based on consideration of your individual circumstances, and you should determine on your own whether you agree with the information contained within or made available via the Services. Employees involved in Panjiva Research may hold positions in securities analyzed or discussed in the Services. Panjiva does not make any express or implied warranties, representations, endorsements or conditions with respect to the Services and the information contained within or made available via the Services, including without limitation, warranties as to the usefulness, completeness, accuracy, currentness, reliability or sufficiency of any information (including, without limitation, conclusions, statements, opinions, estimates, forecasts or projections of any kind) and expressly disclaims any implied warranties. Neither this disclaimer nor any of its contents may be forwarded or redistributed without the prior written consent of Panjiva. © 2019 Panjiva, Inc. All Rights Reserved.